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ABSTRACT
Background: Treatment of ST-elevation acute myocardial 
infarction has primary percutaneous coronary intervention 
as the preferred method of reperfusion. This study aimed to 
evaluate in-hospital outcomes of patients with ST-elevation 
acute myocardial infarction according to the total ischemic 
time until performing primary percutaneous coronary interven-
tion. Methods: Single-center registry of patients admitted with 
ST-elevation acute myocardial infarction undergoing primary 
percutaneous coronary intervention between March/2012 
and February/2014, followed from admission to hospital dis-
charge, and compared according to the total ischemic time 
(Group 1: symptom onset-to-balloon time < 6 hours; Group 
2: symptom onset-to-balloon time ≥ 6 and < 12 hours). Re-
sults: Two hundred seventy nine patients underwent primary 
percutaneous coronary intervention, 118 in Group 1 (42.3%) 
and 161 in Group 2 (57.7%). Group 2 was older, had higher 
prevalence of hypertension, fewer smokers, more patients 
in Killip-Kimball class ≥ 2 and lower primary percutaneous 
coronary intervention success rate. The incidences of death or 
non-fatal infarction (11.0% vs. 18.6%; p = 0.08), death (8.5% 
vs. 16.8%; p = 0.04) and acute renal failure (7.6% vs. 19.9%; 
p < 0.01) were greater in Group 2. Conclusions: Patients with 
ST-elevation acute myocardial infarction undergoing primary 
percutaneous coronary intervention with symptom onset-to- 
balloon time ≥ 6 hours presented higher clinical complexity 
and worse in-hospital outcomes when compared to patients 
treated earlier. Joint actions in different critical areas of patient 
care are essential to increase treatment efficacy and reduce 
adverse outcomes.
DESCRIPTORS: Myocardial infarction. Percutaneous coronary 
intervention. Myocardial reperfusion. Mortality.
1 Hospital Evangélico de Vila Velha, Vila Velha, ES, Brazil.
2 Escola Superior de Ciências da Santa Casa de Misericórdia, Vitória, 
ES, Brazil.
Correspondence to: Roberto Ramos Barbosa. Rua Mato Grosso, 80, apto. 
602 − Praia da Costa − CEP: 29101-120 − Vila Velha, ES, Brazil
E-mail: roberto.rb@cardiol.br
Received: 04/02/2014 • Accepted: 06/08/2014
RESUMO
Resultados da Intervenção Coronária Percutânea 
Primária de Acordo com o Tempo Total de Isquemia 
Introdução: O tratamento do infarto agudo do miocárdio 
com supradesnivelamento de ST tem a intervenção coronária 
percutânea primária como método preferencial de reperfusão. 
Este estudo teve como objetivo avaliar a evolução hospitalar 
de pacientes com infarto agudo do miocárdio com suprades-
nivelamento de ST, conforme o tempo total de isquemia, até 
a realização de intervenção coronária percutânea primária. 
Métodos: Registro unicêntrico, de pacientes admitidos com 
infarto agudo do miocárdio com supradesnivelamento de ST 
submetidos à intervenção coronária percutânea primária entre 
março de 2012 e fevereiro de 2014, acompanhados da admissão 
até a alta hospitalar e comparados conforme o tempo total de 
isquemia (Grupo 1: tempo dor-balão < 6 horas; Grupo 2: tempo 
dor-balão ≥ 6 e < 12 horas). Resultados: Foram submetidos 
à intervenção coronária percutânea primária 279 pacientes, 
sendo 118 do Grupo 1 (42,3%) e 161 do Grupo 2 (57,7%). 
O Grupo 2 apresentou idade mais avançada, maior prevalên-
cia de hipertensão arterial, menor proporção de tabagistas, 
maior número de pacientes em classe Killip-Kimball ≥ 2 e 
menor taxa de sucesso da intervenção coronária percutânea 
primária. As incidências de óbito ou infarto não fatal (11,0% 
vs. 18,6%; p = 0,08), óbito (8,5% vs. 16,8%; p = 0,04) e 
insuficiência renal aguda (7,6% vs. 19,9%; p < 0,01) foram 
maiores no Grupo 2. Conclusões: Pacientes com infarto agudo 
do miocárdio com supradesnivelamento de ST submetidos à 
intervenção coronária percutânea primária com tempo dor-
balão ≥ 6 horas apresentaram maior complexidade clínica e 
pior evolução hospitalar em relação àqueles tratados mais 
precocemente. Ações conjuntas em diversos pontos críticos 
da assistência ao paciente são fundamentais para aumentar 
a eficácia do tratamento e reduzir os desfechos adversos.
DESCRITORES: Infarto do miocárdio. Intervenção coronária 
percutânea. Reperfusão miocárdica. Mortalidade.
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A cute myocardial infarction (AMI) has a high inci-dence and is currently a leading cause of death in Brazil, in addition to generating large expenditures, 
of both financial and technological resources, by the 
country’s health care systems. The increasing number 
of cases of AMI, particularly in developing countries, is 
presently one of the most relevant public health issues.1 
There are very robust, evidence-based scientific data 
regarding the clinical benefit of primary percutaneous 
coronary intervention (PPCI) in acute myocardial infarc-
tion with ST-segment elevation (STEMI).2-5 However, 
some obstacles can directly influence the treatment 
of patients with AMI. In this context, primary PCI 
should be made available in centers with interventional 
cardiology training, and reducing the time between 
symptom onset and the procedure is associated with 
a higher rate of culprit artery patency, smaller infarct 
size, and lower mortality.6 For that to occur, it is neces-
sary the combine the actions of several professionals 
in an integrated and efficient system, which includes 
symptom recognition by population, disease diagnosis 
at the service of arrival, patient transportation to the 
referral service, and finally, the engagement of the 
interventional cardiology team. 
In the guidelines of the Brazilian Society of Car-
diology, the indication for primary PCI from up to 90 
minutes of the first medical contact for patients with 
STEMI in the acute phase (with symptoms that started 
less than 12 hours before) receives Class I recommenda-
tion, level of evidence A.7 Although the performance of 
primary PCI within 12 hours of the onset of STEMI is 
universally accepted, agility and the reduction of the 
delay until coronary reperfusion therapy are constantly 
sought. Thus, this study aimed to evaluate the clinical 
evolution of patients with STEMI, according to the 
total ischemic time until the performance of the PPCI. 
METHODS
Study design and population
This was an observational study of a single center 
registry of patients admitted with STEMI, submitted 
to PPCI between March 2012 and February 2014 at 
Hospital Evangélico de Vila Velha, located in Vila Velha 
(ES), followed from hospital admission until discharge 
or death. This series included consecutive patients older 
than 18 years who underwent primary PCI within 12 
hours of the onset of AMI, with persistent ST-segment 
elevation or new left bundle branch block on ECG, and 
treated by the Brazilian Unified Health System (Sistema 
Único de Saúde – SUS). Patients undergoing primary 
PCI with STEMI onset of more than 12 hours were 
excluded from the study, as well as those for whom 
there were doubts about the diagnosis of STEMI by the 
Clinical Cardiology and Interventional Cardiology staff. 
Patients included in the study were divided into 
two groups according to the total time of ischemia; 
Group 1, with symptom-onset-to-balloon time <  6 
hours, and Group 2, with symptom-onset-to-balloon 
time ≥  6 and <  12 hours. 
The data obtained from the medical records were 
stored prospectively in the service in registry format. 
All patients signed an informed consent prior to the 
procedures. The study was approved by the Research 
Ethics Committee under protocol number 492.764. 
PrOcEDurES
Hospital Evangélico de Vila Velha is a referral 
center of SUS for cardiovascular emergencies in the 
metropolitan region of Vitoria. The Service of Inter-
ventional Cardiology and Hemodynamics comprises 
medical and nursing staff in attendance 24 hours a 
day, 7 days a week, working together with the clinical 
cardiology team. 
All patients were assessed regarding the emergency 
nature of the primary PCI procedure, and patients were 
taken to the invasive procedure room as soon as pos-
sible after a communication with the emergency room 
team. Patients received a loading dose of 200 to 300 
mg of acetylsalicylic acid and 300 to 600 mg of clopi-
dogrel, or 180  mg of ticagrelor. The use of morphine, 
sublingual/intravenous nitrate, or beta-blocker was at the 
discretion of the attending physician. All underwent full 
heparinization with unfractionated heparin immediately 
before the intervention (60 to 100 U/kg). 
The PPCI was performed as recommended by 
guidelines,7 and the vascular access route was at the 
interventionist’s discretion. Pre-dilation, post-dilation, 
and administration of glycoprotein IIb/IIIa inhibitors 
were performed at the surgeon’s discretion.
Definitions and Outcomes
In addition to the time of symptom onset-to-balloon, 
the following times were also analyzed: symptom onset-
to-door time (from symptom onset to arrival at the first 
health service); inter-hospital transfer time (time elapsed 
from arrival at the first health service until arrival at the 
referral service, i.e., the emergency room of Hospital 
Evangélico de Vila Velha), for cases that were not ini-
tially seen at the referral service; and door-to-balloon 
time (interval between arrival at the emergency referral 
service to the performing PPCI).
Hospitalization was recorded in days, from the day 
of admission, considered as zero day. In the analysis 
of length of hospitalization, only patients who were 
discharged to home were considered, excluding those 
who died during the hospitalization.
Regarding mortality, hospital mortality was con-
sidered as cases of death from any cause after the 
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procedure. Non-fatal myocardial infarction was defined 
as elevation of CK-MB to three times above baseline 
or troponin five times above baseline, in association 
with recurrent symptoms of myocardial ischemia and/
or ECG changes compatible with ischemia. 
The primary endpoint was the combined occurrence 
of cardiac events, death from any cause, or non-fatal 
AMI (with or without new coronary artery bypass graft 
surgery [CABG]) during hospitalization. Secondary out-
comes were isolated occurrences of death and non-fatal 
myocardial infarction, in addition to acute renal failure 
(characterized by increased serum creatinine >  50% 
from baseline or need for dialysis) and major bleeding 
according to the Global Utilization of Streptokinase and 
Tissue Plasminogen Activator for Occluded Coronary 
Arteries (GUSTO) criteria.8
Statistical Analysis
In the descriptive analysis, categorical variables 
were expressed as absolute frequencies and percent-
ages, and continuous variables as means and standard 
deviations. Statistical analysis was performed using SPSS 
version 11.0 for Windows and the chi-squared test or 
Fisher’s exact test were used, as appropriate, to compare 
the qualitative variables, whereas Student’s t-test was 
used for quantitative variables; p-values <  0.05 were 
considered statistically significant, with a confidence 
interval of 95%. 
rESuLTS
Between March 2012 and February 2014, 279 pa-
tients with STEMI were admitted and underwent PPCI, 
of whom 118 (42.3%) with symptom onset-to-balloon 
time <  6 hours were allocated to Group 1, whereas 
161 with symptom onset-to-balloon ≥ 6 hours and < 12 
hours were allocated to Group 2. 
Patients in Group 2 were older and had higher 
prevalence of hypertension and lower rate of current 
smoking. This group showed more severe clinical pre-
sentation of STEMI at hospital admission, according to 
the Killip-Kimball classification, with 24.8% in class 
≥ 2 and 11.0% in Group 1 (p  <  0.01). The baseline 
clinical characteristics are shown in Table 1. 
The mean duration of STEMI until the performance 
of PPCI was 3.7 ± 1.4 hours in Group 1 and 11.4 ± 
2.0 hours in Group 2. A total of 83.0% of patients in 
Group 1 and 84.4% in Group 2 (p = 0.75) needed an 
inter-hospital transfer to undergo primary PCI. Analysis 
of partial delay times to PPCI showed, respectively, 
in Groups 1 and 2, symptom onset-to-door of 1.2 ± 
0.9 hours vs. 3.5 ± 2.1 hours (p  <  0.01), duration of 
inter-hospital transfer of 2.5 ± 1.0 hours vs. 6.0 ± 2.3 
hours (p < 0.01), and door-to-balloon time of 62 ± 39 
minutes vs. 140 ± 84 minutes (p  <  0.01). 
In total, the vascular access route used for PPCI 
was the femoral artery in 93.5% of procedures, whereas 
the radial approach was used in the remaining cases. A 
total of 351 coronary stents were implanted, all bare-
metal, with a mean of 1.3 ± 0.5 stents per patient. 
Glycoprotein IIb/IIIa inhibitors were administered to 
33.0% of patients in Group 1 and 32.9% of patients 
in Group 2 (p  =  0.90). Flow disturbances (slow-flow 
or no-reflow) after recanalization of the culprit vessel 
occurred in 21.1% patients in Group  1 and 26.0% in 
Group 2 (p = 0.34). After PPCI, staged PCI procedure 
was performed in 34.7% and 27.9% of patients, re-
spectively (p = 0.22). Table 2 shows the angiographic 
characteristics and the treated vessels in the two groups. 
The success rate of primary PCI procedure was 
94.1% in Group 1 and 85.1% in Group 2 (p = 0.01). 
Among patients who were discharged by the medical 
team, the mean hospitalization was 7.9 ± 5.2 days in 
Group 1 and 9.2 ± 6.1 days in Group 2 (p  =  0.06). 
Adverse outcomes and complications observed during 
the hospitalization period are shown in Table 3. 
DIScuSSION
The delay in the implementation of coronary 
reperfusion therapy in STEMI has been the subject of 
TABLE 1  
Basal clinical characteristics
Group 1 
(n = 118)
Group 2 
(n = 161) p-value
Age, years 57.7 ± 10 61.1 ± 13 0.01
Male gender, n (%) 95 (80.5) 123 (76.4) 0.41
Arterial 
hypertension, n (%)
74 (62.7) 120 (74.5) 0.03
Diabetes mellitus, 
n (%)
32 (27.1) 49 (30.4) 0.54
Dyslipidemia, n (%) 43 (36.4) 56 (34.7) 0.70
Smoking, n (%) 51 (43.2) 50 (31.0) 0.03
Chronic renal 
failure, n (%)
9 (7.6) 22 (13.6) 0.11
Previous 
percutaneous 
coronary 
intervention, n (%)
11 (9.3) 10 (6.2) 0.30
Previous CABG, n (%) 6 (5.1) 2 (1.2) 0.05
Killip-Kimball 
classification, n (%)
< 0.01
I 105 (88.9) 120 (74.5)
II 7 (5.9) 13 (5.1)
III 1 (0.8) 6 (3.7)
IV 5 (4.2) 21 (13.0)
CABG, coronary artery bypass graft surgery.
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discussion regarding the adoption of health policies, 
and has shown to be an important adverse prognostic 
predictor.9-11 In this study, increased time from symptom 
onset to the performance of PPCI was directly related 
to the occurrence of serious adverse events during 
hospitalization, including mortality. 
There is great difficulty in determining the causal 
relationship between the increase in the time of 
STEMI evolution and clinical complexity. This study 
identified an older mean age and a higher prevalence 
of hypertension in Group 2, although with a lower 
proportion of smokers in this group. Other clinical 
variables such as gender, diabetes mellitus, and 
dyslipidemia showed no statistically significant dif-
ferences between groups. Elderly patients and those 
with more comorbidity may have atypical clinical 
pictures as the initial manifestation of AMI, which 
may explain delays in several points of the healthcare 
network when treating AMI, culminating in significant 
increase in symptom onset-to-balloon time.
The severity of the clinical picture at hospital ad-
mission in STEMI was higher in patients from Group 
2, with a higher proportion of individuals in classes 
II, III, and IV of Killip-Kimball, when compared with 
Group 1. Again, it was not possible to determine clearly 
whether the cause of clinical deterioration was the delay 
until arrival at the referral emergency room service, or 
if the opposite way should be considered – that the 
severity of the case is the greatest cause of delay, pos-
sibly requiring initial clinical stabilization, endotracheal 
intubation, and adequately equipped mobile units to 
perform inter-hospital transfer, which can lead to delay 
until the primary PCI.
The analysis of time delays during the phases of 
STEMI care is essential to identify deficiencies in the 
health system. It was observed that there was considerable 
delay at several points in time, from the identification 
of the clinical picture and transportation of the patient 
to a health service until the transfer and performance 
of primary PCI in the referral service. A particular point 
of concern was the mean time for inter-hospital transfer 
of more than two hours, including in Group 1. In a 
prior publication, Brazilian data demonstrated that the 
fact that patients will initially seek a Basic Health Unit 
substantially increases the time of evolution of STEMI 
until coronary reperfusion therapy.11 In the present 
study, the delay in the referral service (door-to-balloon) 
was abbreviated whenever possible, reaching a mean 
door-to-balloon time of the entire sample of 104 ± 
95 min (62 ± 39 minutes in Group 1 and 140 ± 84 
minutes in Group 2). The work of the interventional 
cardiology team in attendance played a significant role 
in optimizing this step of assistance to AMI. 
The lowest total time of ischemia (symptom-onset-
to-balloon), the object of this research, was associated 
with lower incidence of clinical outcomes in the treat-
ment of STEMI with PPCI, as previously demonstrated.12 
In an electrocardiographic subanalysis of the PLATelet 
Inhibition and Patient Outcomes (PLATO) trial, 70% of 
patients randomized in the range 3 to 6 hours of symp-
tom onset exhibited ST-segment resolution, compared 
to 51% of those randomized after 6 hours.13 A similar 
result was found by Andrade et al.,14 who demonstrated 
the association of longer ischemic time with incomplete 
resolution of ST-segment elevation.
TABLE 2  
Angiographic characteristics
Group 1  
(n = 118)
Group 2  
(n = 161) p-value
Treated vessels, 
n (%)
0.77
Left anterior 
descending artery
58 (49.2) 80 (49.7)
Left circumflex 
artery
17 (14.4) 21 (13.0)
Right coronary 
artery
42 (35.6) 56 (34.8)
Left main 
coronary artery
1 (0.8) 4 (2.5)
Saphenous vein 
graft lesion, n (%)
3 (2.5) 0 (0) 0.07
Bifurcation lesion, 
n (%)
14 (11.9) 31 (19.2) 0.09
Nominal stents 
diameter, mm
2.99 ± 0.42 3.02 ± 0.41 0.54
Nominal stent 
length, mm
22.4 ± 6.7 22.9 ± 6.2 0.77
Pre-dilation, n (%) 94 (79.6) 120 (74.5) 0.31
Post-dilation, n (%) 43 (36.4) 43 (26.7) 0.08
TABLE 3  
Incidence of adverse cardiac events  
and in-hospital complications
Group 1 
(n = 118)
Group 2 
(n = 161) p-value
Death ornon-fatal 
acute myocardial 
infarction n (%)
13 (11.0) 30 (18.6) 0.08
Death, n (%) 10 (8.5) 27 (16.8) 0.04
Non-fatal acute 
myocardial 
infarction, n (%)
3 (2.5) 3 (1.9) 0.69
Major bleeding, 
n (%)
7 (5.9) 12 (7.4) 0.61
Acute renal 
failure, n (%)
9 (7.6) 32 (19.9) < 0.01
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The survival benefits and other relevant outcomes, 
associated with a lower symptom onset-to-balloon 
time, can be observed even in long-term evolution.15-17 
However, the measurement of this time interval, unlike 
the door-to-balloon time, is subject to bias, such as the 
uncertainty of the time of symptom onset by patients and 
variations in the temporal course of myocardial necrosis 
development. Still, it should be taken into account, as 
it reflects the results of joint activities at several criti-
cal points of care for AMI, including identification of 
symptoms, accessibility, and pre-hospital care.15
Thus, aggressive goals in STEMI assistance poli-
cies must be sought in order to promote flexibility in 
care. However, in Brazil, the prescription for coronary 
reperfusion therapies in the setting of AMI is far from 
ideal, with gaps and missed opportunities for treatment, 
based on the directions of the current guidelines.18 In 
2013, Correia et al.19 described the effectiveness of an 
assistance quality protocol to reduce door-to-balloon time 
in STEMI. Comparing the protocol pre-implementation 
period with successive periods over 22 months, there 
was progressive reduction of the time described, with 
the last patients included reaching a time of 116 ± 
29 minutes – comparable to the times obtained in 
the present study. It is noteworthy that the systematic 
measurement of door-to-balloon time can disclose the 
inadequacy of the process, and that the adoption of an 
evidence-based protocol can improve the performance 
of medical services in acute myocardial infarction.
Results of a Brazilian study brought to light im-
portant data on current clinical outcomes of AMI in 
Brazil. The Acute Coronary Care Evaluation of Practice 
Registry (ACCEPT) registry had the participation of 47 
centers of excellence and included 2,475 patients with 
acute coronary syndrome, between August 2010 and 
December 2011. PCI was performed in 75.2% of cases 
of STEMI and the mean time of delay until PPCI was 
125 ± 90 minutes. Cardiac mortality in STEMI, after 
dividing those submitted or not to CABG, was 2.0% 
vs. 8.1% (p  <  0.001).18
Efficient public systems for the treatment of AMI 
should be adapted to the reality of each region of the 
world, and are desirable, as their implementation can 
shorten any delay times to treatment access. When bar-
riers to early accessibility are removed, the effectiveness 
of the treatment increases and adverse outcomes are 
reduced. Therefore, it is possible to reduce mortality 
from AMI, reduce cardiac sequelae in the long term, 
improve the quality of life – which is directly related 
to quality of care in health and its preventive measures 
– and redirect economic resources of public health poli-
cies to meet other needs, such as primary prevention. 
Despite showing significant results in agreement 
with previously published studies, this study has limita-
tions. In particular, its observational nature and small 
sample size are emphasized, as well as the fact that 
it was a sample from a specific region, which restricts 
data interpretation. As only the univariate analysis 
was performed for comparison purposes, it was not 
possible to establish a clear and independent causal 
association between longer symptom onset-to-balloon 
time and in-hospital outcomes, as there may have been 
interference from unmeasured variables. Still, the pos-
sibility of information bias in relation to the times was 
assumed, which would be natural, due to uncertainties 
regarding the time of symptom onset by patients and 
family members.
cONcLuSIONS
Patients with acute myocardial infarction with ST-
segment elevation submitted to primary percutaneous 
coronary intervention with a total ischemic time ≥  6 
hours had a more complex clinical profile and worse 
in-hospital outcome than those treated earlier. Joint 
actions at several critical points of care, including 
identification of symptoms by the patient, as well as the 
agility of pre-hospital and hospital care, are essential 
to increase the effectiveness of treatment and reduce 
adverse outcomes.
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